1. Harrison KM, Song R, Zhang X. Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr. 2010;53:124–30.
2. Bhaskaran K, Hamouda O, Sannes M, et al. CASCADE Collaboration. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008;300:51–9.
3. Centers for Disease Control and Prevention: Persons Aged 50 Years and Older. Available at: http://www.cdc.gov/hiv/topics/over50/index.htm . Accessed June 16, 2011.
4. Smith C, Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group Association between modifiable and non-modifiable risk factors and specific causes of death in the HAART era: The Data Collection on Adverse Events of Anti-HIV Drug Study. 16th Conference on Retroviruses and Opportunistic Infections; 2009 Feb 8–11; Montreal, Canada. Abstract 145.
5. Mocroft A, Reiss P, Gasiorowski J, et al. Serious fatal and non-fatal non-AIDS-defining illnesses in Europe. Paper presented at: 16th Conference on Retroviruses and Opportunistic Infections; 2009 Feb 8-11; Montreal, Canada. Abstract 707.